BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Stock Fundamental Analysis
FRA:BRYN - US0846707026 - Common Stock
415.5 EUR
-5.05 (-1.2%)
Taking everything into account, BRYN scores 5 out of 10 in our fundamental rating. BRYN was compared to 51 industry peers in the Financial Services industry. BRYN has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on BRYN. With these ratings, BRYN could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
BRYN had positive earnings in the past year.
In the past year BRYN had a positive cash flow from operations.
BRYN had positive earnings in 4 of the past 5 years.
BRYN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
BRYN's Return On Assets of 5.41% is fine compared to the rest of the industry. BRYN outperforms 70.59% of its industry peers.
Looking at the Return On Equity, with a value of 9.42%, BRYN is in line with its industry, outperforming 56.86% of the companies in the same industry.
The Return On Invested Capital of BRYN (4.37%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for BRYN is significantly below the industry average of 11.75%.
The 3 year average ROIC (4.13%) for BRYN is below the current ROIC(4.37%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.41% | ||
| ROE | 9.42% | ||
| ROIC | 4.37% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
1.3 Margins
Looking at the Profit Margin, with a value of 17.00%, BRYN is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Profit Margin of BRYN has declined.
BRYN has a Operating Margin of 15.70%. This is comparable to the rest of the industry: BRYN outperforms 58.82% of its industry peers.
In the last couple of years the Operating Margin of BRYN has grown nicely.
With a Gross Margin value of 16.97%, BRYN is not doing good in the industry: 62.75% of the companies in the same industry are doing better.
BRYN's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.7% | ||
| PM (TTM) | 17% | ||
| GM | 16.97% |
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BRYN is creating some value.
Compared to 1 year ago, BRYN has less shares outstanding
BRYN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BRYN has an improved debt to assets ratio.
2.2 Solvency
BRYN has an Altman-Z score of 1.43. This is a bad value and indicates that BRYN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.43, BRYN is in line with its industry, outperforming 49.02% of the companies in the same industry.
The Debt to FCF ratio of BRYN is 15.44, which is on the high side as it means it would take BRYN, 15.44 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 15.44, BRYN is doing worse than 62.75% of the companies in the same industry.
BRYN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
BRYN has a Debt to Equity ratio of 0.19. This is in the better half of the industry: BRYN outperforms 68.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 15.44 | ||
| Altman-Z | 1.43 |
ROIC/WACC1.36
WACC3.22%
2.3 Liquidity
BRYN has a Current Ratio of 1.95. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
BRYN has a better Current ratio (1.95) than 76.47% of its industry peers.
BRYN has a Quick Ratio of 1.68. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.68, BRYN is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.95 | ||
| Quick Ratio | 1.68 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 8.24% over the past year.
The Earnings Per Share has been growing by 17.78% on average over the past years. This is quite good.
The Revenue has been growing slightly by 0.01% in the past year.
The Revenue has been growing slightly by 7.84% on average over the past years.
EPS 1Y (TTM)8.24%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-3.87%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-1.22%
3.2 Future
The Earnings Per Share is expected to grow by 2.26% on average over the next years.
The Revenue is expected to grow by 4.89% on average over the next years.
EPS Next Y-3.47%
EPS Next 2Y0.07%
EPS Next 3Y2.03%
EPS Next 5Y2.26%
Revenue Next Year0.77%
Revenue Next 2Y0.48%
Revenue Next 3Y1.6%
Revenue Next 5Y4.89%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 0.02, the valuation of BRYN can be described as very cheap.
100.00% of the companies in the same industry are more expensive than BRYN, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of BRYN to the average of the S&P500 Index (27.24), we can say BRYN is valued rather cheaply.
The Price/Forward Earnings ratio is 0.01, which indicates a rather cheap valuation of BRYN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of BRYN to the average of the S&P500 Index (35.82), we can say BRYN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.02 | ||
| Fwd PE | 0.01 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BRYN is valued cheaper than 100.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 100.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 0.08 | ||
| EV/EBITDA | 0.34 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y0.07%
EPS Next 3Y2.03%
5. Dividend
5.1 Amount
No dividends for BRYN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:BRYN (8/22/2025, 7:00:00 PM)
415.5
-5.05 (-1.2%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)
Earnings (Next)
Inst Owners33.77%
Inst Owner ChangeN/A
Ins Owners36.68%
Ins Owner ChangeN/A
Market Cap598.32M
Analysts80
Price Target458.46 (10.34%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-9.78%
Max EPS beat(2)0.19%
EPS beat(4)2
Avg EPS beat(4)5.7%
Min EPS beat(4)-10.41%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)8.53%
EPS beat(12)8
Avg EPS beat(12)6.49%
EPS beat(16)11
Avg EPS beat(16)7.41%
Revenue beat(2)0
Avg Revenue beat(2)-3.21%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)-2.33%
Revenue beat(4)0
Avg Revenue beat(4)-3.53%
Min Revenue beat(4)-7.69%
Max Revenue beat(4)-0.01%
Revenue beat(8)3
Avg Revenue beat(8)-1.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.85%
Revenue beat(16)5
Avg Revenue beat(16)-1.25%
PT rev (1m)-0.64%
PT rev (3m)-3.96%
EPS NQ rev (1m)-1.62%
EPS NQ rev (3m)9.88%
EPS NY rev (1m)2.72%
EPS NY rev (3m)2.36%
Revenue NQ rev (1m)-0.75%
Revenue NQ rev (3m)-2.01%
Revenue NY rev (1m)3.27%
Revenue NY rev (3m)-3.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.02 | ||
| Fwd PE | 0.01 | ||
| P/S | 0 | ||
| P/FCF | 0.08 | ||
| P/OCF | 0.03 | ||
| P/B | 0 | ||
| P/tB | 0 | ||
| EV/EBITDA | 0.34 |
EPS(TTM)27212.33
EY6549.3%
EPS(NY)28461.72
Fwd EY6849.99%
FCF(TTM)4920.58
FCFY1184.26%
OCF(TTM)16399.1
OCFY3946.84%
SpS221441.51
BVpS399622.03
TBVpS328179
PEG (NY)N/A
PEG (5Y)0
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.41% | ||
| ROE | 9.42% | ||
| ROCE | 5.42% | ||
| ROIC | 4.37% | ||
| ROICexc | 4.82% | ||
| ROICexgc | 5.84% | ||
| OM | 15.7% | ||
| PM (TTM) | 17% | ||
| GM | 16.97% | ||
| FCFM | 2.22% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexcg growth 3Y9.15%
ROICexcg growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 15.44 | ||
| Debt/EBITDA | 1.78 | ||
| Cap/Depr | 146.66% | ||
| Cap/Sales | 5.18% | ||
| Interest Coverage | 11.47 | ||
| Cash Conversion | 38.5% | ||
| Profit Quality | 13.07% | ||
| Current Ratio | 1.95 | ||
| Quick Ratio | 1.68 | ||
| Altman-Z | 1.43 |
F-Score4
WACC3.22%
ROIC/WACC1.36
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.24%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-3.87%
EPS Next Y-3.47%
EPS Next 2Y0.07%
EPS Next 3Y2.03%
EPS Next 5Y2.26%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-1.22%
Revenue Next Year0.77%
Revenue Next 2Y0.48%
Revenue Next 3Y1.6%
Revenue Next 5Y4.89%
EBIT growth 1Y6.42%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-68.47%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-36.42%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%